Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
Colorcon
Deloitte
Covington
UBS
McKesson
Merck
US Army

Generated: July 18, 2018

DrugPatentWatch Database Preview

FLUPHENAZINE HYDROCHLORIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Fluphenazine Hydrochloride patents expire, and when can generic versions of Fluphenazine Hydrochloride launch?

Fluphenazine Hydrochloride is a drug marketed by Ani Pharms Inc, Pharm Assoc, Fresenius Kabi Usa, Lannett Co Inc, Mylan, Sandoz, and Watson Labs. and is included in twelve NDAs.

The generic ingredient in FLUPHENAZINE HYDROCHLORIDE is fluphenazine hydrochloride. There are eighteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fluphenazine hydrochloride profile page.
Drug patent expirations by year for FLUPHENAZINE HYDROCHLORIDE
Pharmacology for FLUPHENAZINE HYDROCHLORIDE
Ingredient-typePhenothiazines
Drug ClassPhenothiazine
Synonyms for FLUPHENAZINE HYDROCHLORIDE
1-(2-Hydroxyethyl)-4-(3-(2-trifluoromethyl-10-phenothiazinylpropyl)piperazine dihydrochloride
1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-, dihydrochloride
1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-, dihydrochloride
1-piperazineethanol, 4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-, dihydrochloride
10-(3-(4-(2-Hydroxyethyl)piperazinyl)propyl)-2-trifluoromethylphenothiazine dihydrochloride
146-56-5
2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethan-1-ol dihydrochloride
2-(4-{3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl}-1-piperazinyl)ethanol dihydrochloride
2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethan-1-ol dihydrochloride
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride
36315-90-9
4-(3-(2-(Trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazineethanol dihydrochloride
4-[3-[2-(Trifluoromethyl)-10H-pheno-thiazin-10-yl]-1-piperazineethanol 2HCl
4-[3-[2-(Trifluoromethyl)-10H-pheno-thiazin-10-yl]-1-piperazineethanol dihydrochloride
4-[3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride
A 4077
AB0019790
AC-12201
AC1L27DO
AC1Q3ALH
AKOS015960787
Ambap146-56-5
Anatensol
API0002739
C22H26F3N3OS
C22H27ClF3N3OS
Calmansial
CCG-212902
CCRIS 4032
CHEBI:5126
CHEMBL1448187
CS-4290
CTK8F9824
D00791
Dapotum
EINECS 205-674-1
EU-0100555
F 4765
Flufenazin
FLUFENAZINE HYDROCHLORIDE
Fluorophenazine dihydrochloride
Fluphenazine (dihydrochloride)
Fluphenazine chloride
Fluphenazine DiHCl
Fluphenazine dihydrochloride
Fluphenazine Dihydrochloride 1.0 mg/ml in Methanol (as free base)
Fluphenazine dihydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Fluphenazine dihydrochloride, European Pharmacopoeia (EP) Reference Standard
FLUPHENAZINE HCL
Fluphenazine hydrochloride (JAN/USP)
Fluphenazine hydrochloride [BAN:JAN]
Fluphenazine hydrochloride [USP:BAN:JAN]
Fluphenazine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Fluphenazine hydrochloride, United States Pharmacopeia (USP) Reference Standard
FT-0668755
GP2994
HMS1568P22
HMS1921O14
HY-A0081
Liogen
LP00555
LS-112567
Lyorodin
MBHNWCYEGXQEIT-UHFFFAOYSA-N
MFCD00055212
Mirenil
Moditen
MolPort-000-917-736
NCGC00093941-01
NCGC00093941-02
NCGC00093941-03
NCGC00261240-01
NSC 179197
OMCA
Permitil
Permitil hydrochloride
Prestwick_225
Prolixin
Prolixin (TN)
s4569
S4569 Fluphenazine (dihydrochloride).cd
SCHEMBL41634
SPECTRUM1500994
Squibb 4918
Tensofin
Tox21_500555
Trancin
UNII-ZOU145W1XL
V0295
W-108125
Z2784093501
ZOU145W1XL

US Patents and Regulatory Information for FLUPHENAZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride CONCENTRATE;ORAL 073058-001 Aug 30, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 088555-001 Dec 18, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett Co Inc FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride TABLET;ORAL 089743-003 Aug 25, 1988 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharm Assoc FLUPHENAZINE HYDROCHLORIDE fluphenazine hydrochloride ELIXIR;ORAL 040146-001 Aug 21, 1996 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Daiichi Sankyo
Dow
Cerilliant
Teva
Chubb
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.